Laurion Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,157
Closed -$91.7K 459
2024
Q2
$91.7K Buy
+11,157
New +$91.7K ﹤0.01% 392
2023
Q2
Sell
-984,961
Closed -$22.2M 465
2023
Q1
$22.2M Buy
984,961
+150,000
+18% +$3.37M 0.15% 23
2022
Q4
$17.6M Hold
834,961
0.08% 37
2022
Q3
$20.6M Hold
834,961
0.12% 38
2022
Q2
$20.2M Sell
834,961
-33,817
-4% -$819K 0.31% 21
2022
Q1
$22.4M Sell
868,778
-40,173
-4% -$1.04M 0.27% 28
2021
Q4
$28.2M Buy
908,951
+150,000
+20% +$4.66M 0.29% 38
2021
Q3
$18.4M Buy
758,951
+191,768
+34% +$4.65M 0.08% 69
2021
Q2
$8.28M Buy
567,183
+304,170
+116% +$4.44M 0.05% 82
2021
Q1
$6.57M Buy
+263,013
New +$6.57M 0.04% 141
2015
Q3
Sell
-227,898
Closed -$7.56M 642
2015
Q2
$7.56M Sell
227,898
-192,779
-46% -$6.39M 0.07% 58
2015
Q1
$10.1M Buy
420,677
+233,498
+125% +$5.59M 0.2% 26
2014
Q4
$2.29M Buy
+187,179
New +$2.29M 0.05% 56